Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)

The Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)

The investigators are conducting a 5-year prospective, 2:1 cluster-randomized controlled trial, funded by the Centers for Disease Control (CDC), which provides vision screenings to underserved New York City residents living in affordable housing buildings in Harlem and Washington Heights.

This study aims to increase engagement, detection and management of glaucoma, vision impairment, cataracts, and other eye diseases in vulnerable populations living in New York City. This study considers disparities by race, ethnicity, gender, geography, and socioeconomic status using innovative approaches such as patient navigators. Individuals over the age of 40 living in New York City Housing Authority (NYCHA) Housing buildings are eligible.

Inclusion Criteria:

• Individuals over age 40
• Living independently in NYCHA housing building or attending DFTA Senior Center
• Willing to answer COVID-19 symptom questions
• Willing to consent for 2 vision screening visits at baseline and 12-month follow-up

Exclusion Criteria:

• Self-reported terminal illness with life expectancy less than 1 year
• Inability to provide informed consent due to dementia or other reasons